Cancer care in Singapore: the limits that are published, and the comparison that is not

Cancer care in Singapore is concentrated in two national centres and spread across every general hospital and a handful of private groups. Where a patient ends up depends on the route in, the tumour type, and increasingly on which drugs the treatment needs and how they are paid for. This entry lists the ten providers that handle most of the work, how referral reaches them, and how the bill is built.

What decides the outcome

Speed to diagnosis. A suspected cancer referral from a polyclinic or GP is fast-tracked at every public hospital. The route that matters is the one that gets a biopsy done within two weeks, not the one with the best-known name.

Tumour board. The national centres and the larger general hospitals run multidisciplinary tumour boards where surgeons, medical oncologists, radiation oncologists and pathologists agree a plan. Ask whether your case went to one.

Drugs and the list. Since 2022 MediShield Life and Integrated Shield Plans pay for cancer drugs only if the drug and indication are on the Ministry of Health’s Cancer Drug List, with a monthly claim limit per treatment. A drug off the list is paid in cash or from a separate rider. This shapes treatment choices more than any hospital’s reputation.

National Cancer Centre Singapore

NCCS, in the SingHealth cluster, is the largest cancer centre in the country and moved into a new building on the Outram campus in 2023. It runs medical, surgical and radiation oncology, a proton therapy centre, and the national cancer registry’s largest patient base. Referrals come from polyclinics, GPs and every SingHealth hospital. Subsidised and private patients are seen in the same centre.

National University Cancer Institute, Singapore

NCIS at NUH is the NUHS cluster’s cancer centre, with a documented emphasis on haematological cancers and bone marrow transplant, gastrointestinal and breast cancers, and early-phase clinical trials through the university. Western polyclinics refer here; so do NUH’s own departments.

Tan Tock Seng Hospital — Cancer services

TTSH runs medical oncology, radiation oncology and surgical oncology for the National Healthcare Group and holds the central region’s referrals. Complex and rare cases are referred to NCCS under a long-standing arrangement.

Changi General Hospital and Sengkang General Hospital

Both SingHealth general hospitals run medical oncology clinics, day chemotherapy units and surgical oncology, and refer radiation therapy and complex cases to NCCS. For eastern and north-eastern residents they are the subsidised route for chemotherapy close to home.

KK Women’s and Children’s Hospital

KKH treats gynaecological cancers for adults and all childhood cancers for the SingHealth cluster, including the national paediatric oncology service. Children with suspected cancer anywhere in the country are usually referred to KKH or NUH.

Parkway Cancer Centre

The largest private oncology group, with clinics at Mount Elizabeth Orchard, Mount Elizabeth Novena and Gleneagles. Medical and radiation oncology, haematology and surgical oncology through the hospitals’ surgeons. Private rate, same-week appointments, and a large international patient practice.

Raffles Cancer Centre

Raffles Hospital’s in-house oncology service with published fees, chemotherapy day unit and radiation therapy on site. As with other Raffles specialties, the group structure means a GP referral from any Raffles clinic moves within one system.

OncoCare Cancer Centre

A private medical oncology group with clinics at several private hospitals, staffed largely by oncologists who trained in the public centres. Medical oncology only; surgery and radiation are arranged with the host hospital.

Icon Cancer Centre

An Australian-owned private group with clinics at Mount Alvernia, Farrer Park and Novena, offering medical oncology and haematology and, at some sites, radiation therapy. Fees are private-rate; the group markets package pricing for common regimens.

Public versus private, in practice

	Public, subsidised	Public, private rate	Private group
Time to first appointment, suspected cancer	Within 2 weeks	Within 2 weeks	Days
Consultant choice	No	Yes	Yes
Drugs on the Cancer Drug List	Subsidised and claimable	Claimable	Claimable
Drugs off the list	Cash	Cash	Cash or rider

Two rows have been removed: a chemotherapy cycle and a radiation course, each given as a band across three settings. Nothing published supported them. Cancer treatment costs depend on the regimen, the number of cycles, the stage and the specific drug, and a single band across all of that is a guess wearing a table’s clothes.

What the scheme will pay, which is published

You cannot get a reliable price in advance. You can get the ceiling, because MediShield Life publishes what it will pay per treatment.

Treatment	Claim limit
Cancer drug treatment	S$200 to S$12,800 per month, by drug
Cancer drug services	S$4,500 a year, one primary cancer
Cancer drug services, multiple primary cancers	S$9,000 a year
External radiotherapy, except hemi-body	S$400 per treatment
Brachytherapy, and hemi-body	S$620 per treatment
Stereotactic radiotherapy	S$460 per treatment
Radiosurgery, including category 4 proton beam	S$15,700 per course

The drug row is the one to sit with. The range runs sixty-four fold, and which end applies depends on the specific agent rather than on your diagnosis or your hospital. Two people with the same cancer can have limits S$200 and S$12,800 apart because they are on different drugs.

That is why the single most useful question at the start of treatment is not what the course costs, but which Cancer Drug List entry your drug sits on, and what the limit for that entry is. The treating centre can answer it, and the answer determines more of your bill than the choice of hospital does.

Remember too that these are the scheme’s limits, not the price. Bills outside subsidised wards are pro-rated before the limits are applied, so a private course meets the cap sooner than the figures alone suggest.

Is a private cancer centre better than a public one?

This entry does not answer that, and it is worth being explicit about why.

No published outcome comparison between Singapore’s public and private cancer providers was found. The national centre publishes that it runs the largest number of oncology clinical trials in the country — a real claim, and a meaningful one if trial access matters to you, but a claim about research volume rather than about survival or complication rates. Nothing comparable is published by the private groups, so there is no like-for-like comparison to make.

What can be compared is concrete: whether your drug is on the Cancer Drug List and what its limit is, whether the centre runs trials you might be eligible for, how the bill is pro-rated in your setting, and how quickly you are seen. Those four are answerable before you commit. “Better” is not.

How cancer drugs are paid for

MediShield Life pays a fixed monthly amount for drugs on the Cancer Drug List, by drug and indication. Integrated Shield Plans pay a multiple of that amount, set by tier. Both schemes also cover cancer drug services — consultations, scans and blood tests during treatment — up to an annual limit. A drug that is not on the list for your indication is not claimable from either, and some insurers sell a separate rider that covers off-list drugs up to a cap. Ask the oncologist for the list status of every drug in the plan before the first cycle.

Frequently asked questions

Which hospital is best for cancer in Singapore?

NCCS and NCIS see the most patients and run the most trials. The general hospitals treat common cancers with the same protocols closer to home. For rare tumours, ask for a referral to a national centre; for common ones, the nearest public hospital is usually the right choice.

Do I need a referral to see an oncologist?

For a subsidised appointment, yes, from a polyclinic or a CHAS GP. Private groups take direct bookings, and a GP letter with the biopsy result speeds everything up.

Are cancer drugs subsidised for citizens?

Drugs on the Cancer Drug List are subsidised in public hospitals for subsidised patients, and claimable from MediShield Life for all. Off-list drugs are neither.

Can I get treatment at a private hospital and still claim?

Yes, from an Integrated Shield Plan on the private tier, for listed drugs and services within the plan’s limits. MediShield Life alone will cover a small fraction of a private bill.

Check also

• Hospitals in Singapore: the specialty index — the referral route into every specialty
• MediSave and MediShield Life explained — how the drug and treatment claims are settled
• Integrated Shield Plans in Singapore, compared — the tiers and what they multiply

Where this index comes from

The claim limits were read on 24 September 2026 from the Ministry of Health’s MediShield Life benefits page, which dates itself 3 June 2026. They are kept as data alongside the entry so a later check can report which have moved.

No figure here comes from a private price guide, and no cost band appears at all. The two that did were removed because nothing published supported them.

The statement about clinical trial volume is the national centre’s own, read on the same date. The absence of an outcome comparison is recorded as an absence: no published like-for-like comparison was found, which is not the same as knowing the providers perform alike.

This round verified the limits only. The centre descriptions and the referral routes were not re-sourced, so the date applies to the figures and not to the prose around them.